RTW Biotech Opportunities Ltd (RTW.L)
LSE · USD · Financial Services · Asset Management
$2.39 (+2.58%) as of
Key statistics
- Market cap
- 764.96M
- P/E (TTM)
- 1.88
- EPS (TTM)
- 1.2700
- Dividend yield
- 0.00%
- 52-week range
- 1.7400 – 2.6400
- Beta
- 0.78
- Revenue (TTM)
- 13.54M
- Profit margin
- 3,360.46%
- Volume
- 289.70k
About RTW Biotech Opportunities Ltd
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
- Sector
- Financial Services
- Industry
- Asset Management
- Headquarters
- New York, NY, United States
rtwfunds.com/rtw-biotech-opportunities-ltd
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.